bristol meyers squibb

According to a recent survey, wealthy U.S. investors are the most optimistic than they've been in months. And of those looking to invest more in the stock market, they have several clear ideas on where they'd like to place their bets.

While painful (for most folks) to watch, the actor's explosion has created a bonanza for the tabloid mill. But on a broader level, Sheen has also offers a potential shot in the arm for companies across the spectrum, from media to pharmaceuticals. Hey Viacom, how about Charlie's Family?

AstraZeneca (AZN) has had a good week with its anticlotting drug Brilinta (ticagrelor). It impressed many observers by announcing positive results of a late-stage head-to-head study and a mid-stage study for Brilinta, and on Thursday, it said it had filed for Food and Drug Administration approval....